Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans.
Hall
Ralph F
RF
University of Minnesota Law School and Baker & Daniels LLP, Indianapolis, IN and Washington, D.C., and MR3 Medical, LLC, USA.
Sobotka
Elizabeth
E
D000329:Advertising / Q000331:legislation & jurisprudence; D002961:Civil Rights / Q000331:legislation & jurisprudence; D003132:Commerce / Q000331:legislation & jurisprudence; D018795:Device Approval; D017277:Drug Approval; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D035082:Federal Government; D049673:History, 20th Century; D006801:Humans; D019451:Information Management / Q000266:history / Q000331:legislation & jurisprudence; D035521:Supreme Court Decisions; D014481:United States; D014486:United States Food and Drug Administration